https://www.selleckchem.com/products/kpt-9274.html
Within a scenario analysis, we simulated different time-to-treatment combinations. Half-cycle correction was applied. RESULTS In our simulation, ICBT generated 0.260 QALYs and saved €2536 per patient compared to FCBT. Our deterministic sensitivity analysis suggests that the base-case results were largely unaffected by parameter uncertainty and are therefore robust. Our probabilistic sensitivity analysis suggests that ICBT is highly likely to be more effective (91.5%), less costly (76.0%), and the dominant strategy (69.7%) compared to F
Like
Comment
Share
